1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Antonio Calles Blanco: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lurbinectedin (PM01183) Combined With Pembrolizumab in Small Cell Lung Cancer. Lurbinectedin, Pembrolizumab - Small Cell Lung Carcinoma | Phase 1 / Phase 2 | Completed | Antonio Calles Blanco | 28 | 2020-09-21 | 2025-06-04 |
Recurrence (1) · Small Cell Lung Carcinoma (1)
PM 01183 (1) · pembrolizumab (1)
Spain (1)
Antonio Calles (1)